Optimising monitoring regimens for inhaled uranium oxides.
This paper provides guidance on the most appropriate monitoring procedures and intervals, the likely uncertainties in the assessment of intake and recommendations on appropriate investigation levels for repeated exposures to uranium trioxide, octoxide and dioxide of natural composition.
Stradling
N
N
National Radiological Protection Board, Chilton, Didcot, Oxon OX11 0RQ, UK. neil.stradling@nrpb.org
Hodgson
A
A
Ansoborlo
E
E
Bérard
P
P
Etherington
G
G
Fell
T
T
LeGuen
B
B
D000042:Absorption; D000280:Administration, Inhalation; D000396:Air Pollutants, Radioactive / Q000032:analysis / Q000493:pharmacokinetics*; D000818:Animals; D005243:Feces / Q000737:chemistry*; D006801:Humans; D019570:Inhalation Exposure / Q000032:analysis; D007668:Kidney / Q000378:metabolism*; D008168:Lung / Q000378:metabolism*; D008657:Metabolic Clearance Rate; D009928:Organ Specificity; D011829:Radiation Dosage; D011874:Radiometry / Q000379:methods*; D013909:Thorax / Q000378:metabolism; D017974:Uranium Compounds / Q000008:administration & dosage / Q000032:analysis* / Q000493:pharmacokinetics* / Q000652:urine
D000396:Air Pollutants, Radioactive; D017974:Uranium Compounds; C047385:uranium oxide